TrialArthritis & rheumatology (Hoboken, N.J.)2016

Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1).

Atul A Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.